Upcoming Events
Log In
Pricing
Free Trial

Tumefactive Demyelinating Lesion Summary

HIDE
PrevNext

0:00

I'd like to talk briefly about TDL,

0:03

Tumefactive Demyelinating Lesion.

0:06

These are large demyelinating lesions that may or

0:11

may not be associated with multiple sclerosis.

0:15

These are often single lesions,

0:18

although they may be paired.

0:19

Or sometimes you will see

0:22

multiple lesions that are that large.

0:25

They usually do not show very much mass effect,

0:29

but they will have surrounding edema

0:32

and usually open ring enhancement.

0:36

The differential diagnosis when seeing this,

0:39

often, is a neoplasm.

0:41

And if the patient does not have a preexisting

0:44

diagnosis of multiple sclerosis,

0:47

it can indeed be quite confusing.

0:51

What we generally do in this situation is perform

0:55

cerebral blood perfusion scanning sequences.

1:00

The reason is that most neoplasms that have a

1:04

peripheral rim of enhancement are going to be high

1:07

grade astrocytomas and therefore demonstrate

1:11

increased cerebral blood volume

1:13

and cerebral blood flow.

1:15

Contrast that with tumefactive

1:17

demyelinating lesions or TDLs.

1:19

They usually show low cerebral blood

1:22

volume as opposed to the tumors.

1:25

If you perform magnetic resonance spectroscopy on

1:29

these lesions, you may show high choline,

1:34

but that could be present in both multiple sclerosis,

1:38

as well as in neoplasms.

1:41

The NAA depression is greater in tumors

1:46

than it is in multiple sclerosis,

1:48

but there is a fair amount of overlap.

1:51

So, let's see an example in slides of what we're

1:54

talking about with tumefactive demyelinating lesion

1:57

or tumefactive sclerosis.

2:00

So here, we have a patient who has a very large

2:04

lesion in the right hemisphere

2:06

I'm sorry,

2:07

in the left hemisphere,

2:08

and it does seem to be causing some midline shift.

2:14

So there is an element of mass

2:16

effect from left to right.

2:19

However,

2:20

when we look at the post-gadolinium

2:23

axial and coronal scans,

2:25

this is somewhat bizarre because although

2:28

we have a rim of enhancement,

2:30

it is an incomplete rim of enhancement along the

2:34

medial and inferior border.

2:36

That would be very unusual for a neoplasm.

2:41

So, this would be one indicator that you're dealing

2:44

with a tumefactive demyelinating lesion

2:47

as opposed to a high-grade neoplasm.

2:52

The other thing that we would do, obviously,

2:54

is said we would do perfusion-weighted

2:56

imaging and look at CBV or CBF

3:00

and determine that these are decreased in

3:03

tumefactive demyelinating lesion,

3:06

as opposed to GBMs

3:09

or plastic astrocytomas

3:11

where you have increased cerebral blood volume.

3:15

So if you are confused,

3:17

perform that perfusion-weighted sequence

3:21

in order to make this distinction.

Report

Description

Faculty

David M Yousem, MD, MBA

Professor of Radiology, Vice Chairman and Associate Dean

Johns Hopkins University

Tags

Neuroradiology

MRI

Idiopathic

Brain

Acquired/Developmental

© 2024 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy